lobbying_activities: 2026860

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2026860	24dfea5f-8918-464e-910f-2b1d83b8bdab	Q3	AVENUE SOLUTIONS	72111	JAZZ PHARMACEUTICALS, INC.	2017	third_quarter	PHA	H.R. 2212/S. 974, Creating and Restoring Equal Access to Equivalent Samples Act of 2017 (CREATES Act of 2017); H.R. 2051, FAST Generics Act	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2017-10-17T12:09:22.950000-04:00